BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34481810)

  • 21. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
    Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
    [No Abstract]   [Full Text] [Related]  

  • 22. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday.
    Hamid A; Thomas S; Bell C; Gormley M
    Br J Oral Maxillofac Surg; 2023 Apr; 61(3):227-232. PubMed ID: 36935312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
    Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
    BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
    Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
    Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of severe medication-related osteonecrosis of the jaw.
    Feng Z; An J; Zhang Y; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):43-51. PubMed ID: 38596940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Malignant Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis.
    Yao S; Ding X; Rong G; Zhou J; Zhang B
    J Craniofac Surg; 2023 Mar-Apr 01; 34(2):669-673. PubMed ID: 36184756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
    Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients.
    Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
    Oral Dis; 2022 Jan; 28(1):182-192. PubMed ID: 33254278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
    Soutome S; Otsuru M; Hayashida S; Murata M; Yanamoto S; Sawada S; Kojima Y; Funahara M; Iwai H; Umeda M; Saito T
    Sci Rep; 2021 Aug; 11(1):17226. PubMed ID: 34446755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Type of Antiresorptive Treatment Influences the Time to Onset and the Surgical Outcome of Medication-Related Osteonecrosis of the Jaw.
    Pautke C; Wick A; Otto S; Hohlweg-Majert B; Hoffmann J; Ristow O
    J Oral Maxillofac Surg; 2021 Mar; 79(3):611-621. PubMed ID: 33166522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
    Sakamoto Y; Sawada S; Kojima Y
    Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis.
    Limones A; Sáez-Alcaide LM; Díaz-Parreño SA; Helm A; Bornstein MM; Molinero-Mourelle P
    Med Oral Patol Oral Cir Bucal; 2020 May; 25(3):e326-e336. PubMed ID: 32271321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.